Aquestive Therapeutics
AQST
AQST
35 hedge funds and large institutions have $17M invested in Aquestive Therapeutics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
5% less funds holding
Funds holding: 37 → 35 (-2)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
Holders
35
Holding in Top 10
1
Calls
$20K
Puts
–
Top Buyers
| 1 | +$292K | |
| 2 | +$133K | |
| 3 | +$98.4K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$75.1K |
| 5 |
Renaissance Technologies
New York
|
+$63.9K |
Top Sellers
| 1 | -$457K | |
| 2 | -$104K | |
| 3 | -$81.1K | |
| 4 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
-$54.1K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$27.3K |